secwatch / observer
8-K filed July 15, 2025, 7:59 PM ET ticker VWAV CIK 0002038439
M&A confidence high sentiment neutral materiality 0.75

VisionWave Holdings, Inc. (VWAV): M&A transaction — VisionWave closes merger with Bannix; shares trade on Nasdaq as VWAV

VisionWave Holdings, Inc.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

VisionWave Holdings, Inc.: Company ceased to be a shell company as a result of the business combination.

Change
shell status
Exact text from the filing
As a result of the Business Combination, VisionWave ceased to be a shell company.
View on SEC.gov
M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.95

VisionWave Holdings, Inc. underwent a change of control involving Bannix Acquisition Corp. for All outstanding shares of Bannix Common Stock were cancelled in exchange for a pro-rata portion of 2,540,353 shares of VisionWave Common Stock; substantially eq (closed 2025-07-14).

Action
change of control
Counterparty
Bannix Acquisition Corp.
Consideration
All outstanding shares of Bannix Common Stock were cancelled in exchange for a pro-rata portion of 2,540,353 shares of VisionWave Common Stock; substantially eq
Closing
2025-07-14
Exact text from the filing
of the outstanding shares of common stock, par value $0.01 per share, of Bannix (“Bannix Common Stock”) were cancelled in exchange for the right to receive a pro-rata portion of 2,540,353 shares of common stock of VisionWave (“VisionWave Common Stock”). Each issued and outstanding security of Bannix immediately prior to the Parent Merger Effective Time shall no
View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

VisionWave Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001731122-25-000977
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.